Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2–59 Months of Age, Mongolia, 2015–2021

Starting in June 2016, the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced into the routine immunization program of Mongolia by using a 2+1 dosing schedule, phased by district. We used prospective hospital surveillance to evaluate the vaccine’s effect on pneumonia incidence rates am...

Descrición completa

Detalles Bibliográficos

Principais autores:	Claire von Mollendorf, Munkhchuluun Ulziibayar, Cattram D. Nguyen, Purevsuren Batsaikhan, Bujinlkham Suuri, Dashtseren Luvsantseren, Dorj Narangerel, John de Campo, Margaret de Campo, Bilegtsaikhan Tsolmon, Sodbayar Demberelsuren, Eileen M. Dunne, Catherine Satzke, Tuya Mungun, E. Kim Mulholland
Formato:	Artigo
Idioma:	Inglês
Publicado:	Centers for Disease Control and Prevention 2024-03-01
Series:	Emerging Infectious Diseases
Assuntos:	pneumonia pneumococcal conjugate vaccine PCV13 hospitalization children bacteria
Acceso en liña:	https://wwwnc.cdc.gov/eid/article/30/3/23-0864_article
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!